Common lessons learned from the start-up of precision medicine initiatives
Over recent years, a large number of national and regional initiatives in the field of precision medicine have been established in Europe. In an overview published in Seminars in Cancer Biology, Genomic Medicine Sweden (GMS) and Centers for Personalized Medicine (ZPM)...
GMS’s ambitions for the next 10 years
Genomic Medicine Sweden (GMS) highlights vital aspects for the successful introduction of precision medicine into Swedish healthcare in its Strategy Plan 2021–2030. In Strategy Plan 2021–2030, GMS presents its ambitions for the introduction of precision medicine into...
GMS receives SEK 16.5 million for investment in childhood cancer and cancer that affects women
The government announced today that the National Board of Health and Welfare will be commissioned to pay SEK 16.5 million to GMS to pilots in genetic and molecular diagnostics. Of this, SEK 8.5 million will go to pilot projects that deal with childhood cancer and the...
Report from the first meeting with the GMS Scientific Advisory Board
The Scientific Advisory Board, SAB, is impressive about GMS ‘rapid development and the enormous work that GMS has accomplished. But emphasizes the importance of a formal national leadership structure and lists five important strategic recommendations for further...